Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 9,911,307,200
  • Shares Outstanding, K 65,350
  • 60-Month Beta 0.97
Trade IBB with:
  • Price/Earnings ttm 20.82
  • Annual Dividend & Yield 0.39
  • Most Recent Dividend 0.131
  • Management Fee 0.46%
  • Sectors:

    ETFs - Biotech

Options Overview

Details
  • Implied Volatility 23.31%
  • Historical Volatility 20.61%
  • IV Percentile 7%
  • IV Rank 9.60%
  • IV High 39.72% on 04/23/20
  • IV Low 21.57% on 11/25/20
  • Put/Call Vol Ratio 0.86
  • Today's Volume 1,455
  • Volume Avg (30-Day) 7,610
  • Put/Call OI Ratio 1.66
  • Today's Open Interest 121,944
  • Open Int (30-Day) 86,738

Price Performance

See More
Period Period Low Period High Performance
1-Month
144.82 +5.83%
on 03/30/21
158.73 -3.44%
on 03/22/21
-2.62 (-1.68%)
since 03/19/21
3-Month
142.46 +7.58%
on 03/05/21
174.04 -11.93%
on 02/10/21
-10.26 (-6.27%)
since 01/21/21
52-Week
119.65 +28.10%
on 05/01/20
174.04 -11.93%
on 02/10/21
+30.85 (+25.20%)
since 04/21/20

Most Recent Stories

More News
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

AZN : 52.99 (+1.38%)
PFE : 39.60 (+1.46%)
MRNA : 167.35 (+6.74%)
NVAX : 211.75 (+1.73%)
IBB : 153.72 (+1.41%)
XBI : 130.84 (+1.99%)
BBH : 185.26 (+0.99%)
FBT : 163.12 (+0.64%)
BTEC : 58.11 (+1.98%)
BNTX : 160.30 (+2.64%)
Moderna ETFs to Gain on Positive 'Real-World' Study Data

Positive coronavirus vaccine progress by Moderna (MRNA) grabs investors' attention.

PFE : 39.60 (+1.46%)
MRNA : 167.35 (+6.74%)
IBB : 153.72 (+1.41%)
BBH : 185.26 (+0.99%)
BTEC : 58.11 (+1.98%)
GERM : 36.90 (+1.21%)
Will ETFs Gain on AstraZeneca's Latest Covid-19 Vaccine Update?

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence thanks to multiple mutants.

AZN : 52.99 (+1.38%)
MRNA : 167.35 (+6.74%)
NVAX : 211.75 (+1.73%)
IBB : 153.72 (+1.41%)
CNCR : 29.70 (+2.17%)
XBI : 130.84 (+1.99%)
PPH : 70.27 (+0.89%)
BBH : 185.26 (+0.99%)
Novavax ETFs to Shine Bright on Positive Vaccine Update

Investors are closely tracking the progress in coronavirus vaccine development and distribution amid the pandemic.

JNJ : 166.67 (+0.11%)
NVAX : 211.75 (+1.73%)
IBB : 153.72 (+1.41%)
XBI : 130.84 (+1.99%)
BBH : 185.26 (+0.99%)
GERM : 36.90 (+1.21%)
ETFs to Tap Amgen's Drive for Cancer Deal

Amgen (AMGN) has agreed to buy Five Prime Therapeutics (FPRX) for $1.9 billion.

BMY : 66.41 (+0.50%)
AMGN : 258.50 (-0.25%)
IBB : 153.72 (+1.41%)
FPRX : 38.00 (+0.03%)
BBH : 185.26 (+0.99%)
PJP : 80.15 (+0.83%)
IEIH : 33.28 (+0.84%)
5 ETF Investing Areas for March to Boost Returns

Here we discuss a few ETFs that can enrich investors' portfolio in March amid a strong wave of optimism surrounding the coronavirus vaccine and introduction of another round of fiscal stimulus.

JNJ : 166.67 (+0.11%)
XLE : 47.51 (+0.93%)
IBB : 153.72 (+1.41%)
XBI : 130.84 (+1.99%)
FMAT : 46.07 (+1.34%)
IBUY : 123.11 (+0.72%)
BOTZ : 34.60 (+1.29%)
SKYY : 100.80 (+0.70%)
CLIX : 82.01 (-0.27%)
ROBT : 53.24 (+1.14%)
CLOU : 26.74 (+0.60%)
How Will Biotech ETFs React to These Q4 Earnings Releases?

Let's take a look at some ETFs with exposure to major players in the U.S. biotech industry post their fourth-quarter earnings releases amid the coronavirus crisis.

BIIB : 268.83 (-1.60%)
ALXN : 168.29 (+1.05%)
GILD : 66.73 (+0.53%)
AMGN : 258.50 (-0.25%)
IBB : 153.72 (+1.41%)
XBI : 130.84 (+1.99%)
BBH : 185.26 (+0.99%)
Novavax (NVAX) ETFs to Rise on Impressive Coronavirus Vaccine Update

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

MRNA : 167.35 (+6.74%)
NVAX : 211.75 (+1.73%)
IBB : 153.72 (+1.41%)
XBI : 130.84 (+1.99%)
BBH : 185.26 (+0.99%)
GERM : 36.90 (+1.21%)
Can Moderna ETFs Gain on COVID Vaccine Update Against Variants?

Positive coronavirus vaccine update from Moderna (MRNA) has hogged investors' attention.

MRNA : 167.35 (+6.74%)
IBB : 153.72 (+1.41%)
XBI : 130.84 (+1.99%)
BBH : 185.26 (+0.99%)
BTEC : 58.11 (+1.98%)
GERM : 36.90 (+1.21%)
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis

The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.

PFE : 39.60 (+1.46%)
MRNA : 167.35 (+6.74%)
LLY : 190.72 (+0.06%)
IBB : 153.72 (+1.41%)
CNCR : 29.70 (+2.17%)
XBI : 130.84 (+1.99%)
BBH : 185.26 (+0.99%)
FBT : 163.12 (+0.64%)
SBIO : 47.88 (+1.27%)
PBE : 74.70 (+1.16%)
BTEC : 58.11 (+1.98%)
ARKG : 87.53 (+1.93%)
BNTX : 160.30 (+2.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

3rd Resistance Point 156.39
2nd Resistance Point 154.61
1st Resistance Point 153.10
Last Price 153.77
1st Support Level 149.81
2nd Support Level 148.03
3rd Support Level 146.52

See More

52-Week High 174.04
Last Price 153.77
Fibonacci 61.8% 153.26
Fibonacci 50% 146.85
Fibonacci 38.2% 140.43
52-Week Low 119.65

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar